No Result
View All Result
China Secrets Revealed
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
No Result
View All Result
China Secrets Revealed
No Result
View All Result
Home Investing

Top 3 catalysts for the Nikkei 225 Index this week

by
April 27, 2026
in Investing
0
Top 3 catalysts for the Nikkei 225 Index this week

The Nikkei 225 Index soared to a record high on Monday as investors anticipated a busy market week ahead. It jumped to a high of ¥60,787, much higher than the year-to-date low of ¥50,430. This article looks at some of the top catalysts that will move Japan stocks this week.

Nikkei 225 Index to react to the US-Iran war issues

The main catalyst for the Nikkei 225 Index this week is the progress of the US-Iran war, which has now moved into an open-ended ceasefire arrangement. 

In a statement on Saturday, President Donald Trump said that he had canceled the trip to Pakistan by his representatives as it became clear that the Iranians will not show up.

Iranians have resisted meeting with the US as the US government continues the blockade. As a result, crude oil prices continued rising, with Brent reaching a high of $107 on Monday. Japanese companies are highly exposed to these prices because the country imports most of its energy from the Middle East.

Bank of Japan interest rate decision 

The other main catalyst for the Nikkei 225 Index is the upcoming Bank of Japan interest rate decision that comes on Tuesday this week.

Economists polled by Reuters expect the bank to leave interest rates uncharted at the 30 year high of 0.75%. Officials will justify the rate decision as a way to observe the impact of the war on inflation.

Still, analysts expect that the bank will ultimately hike interest rates by 0.25% later this year as the International Monetary Fund (IMF) has requested. This explains why the short-term Japanese government bonds have soared recently.

In addition to the BoJ decision, the upcoming Federal Reserve interest rate decision will have an impact on the index. A dovish tilt will likely push the index higher.

Top Japanese earnings 

Meanwhile, some important Japanese companies will publish their financial results this week. The most notable of them are the sogo-shoshas, which Warren Buffett has invested in. This includes companies like Mitsubishi, Mitsui, Marubeni, Sumitomo, and Itochu that will release their numbers on Friday.

More large companies like Tokyo Electron, Toyota Tsusho, Hoya, Murata Engineering, Mitsubishi Electric, Fujitsu, and Komatsu will publish their latest results this week. Strong corporate earnings will be highly bullish for the index.

In addition to this, the index will react to the US earnings season, which will accelerate this week with companies like Microsoft, Google, Apple, and Meta Platforms releasing their results.

Nikkei 225 Index technical analysis 

NI225 Index chart | Source: TradingView 

The daily timeframe chart shows that the Nikkei 225 Index has made a strong bullish breakout recently and is now hovering at its highest point on record. It has already moved above the key resistance level at ¥59,297, confirming the cup-and-handle pattern.

The index remains above all moving averages and the strong pivot reverse of the Murrey Math Lines tool. Therefore, the next key resistance level to watch will be at the ultimate resistance at ¥62,500.

The post Top 3 catalysts for the Nikkei 225 Index this week appeared first on Invezz

Previous Post

Hang Seng slips as Asian markets split; Nikkei, Kospi hit new highs

Next Post

Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

Next Post
Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

0
TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

0
Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

0
In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

0
Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

April 27, 2026
Top 3 catalysts for the Nikkei 225 Index this week

Top 3 catalysts for the Nikkei 225 Index this week

April 27, 2026
Hang Seng slips as Asian markets split; Nikkei, Kospi hit new highs

Hang Seng slips as Asian markets split; Nikkei, Kospi hit new highs

April 27, 2026
Meta, Microsoft earnings due next week: here’s what top analysts say

Meta, Microsoft earnings due next week: here’s what top analysts say

April 25, 2026

Recent News

Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

Why is Sun Pharma betting $11.75B on a struggling US drugmaker?

April 27, 2026
Top 3 catalysts for the Nikkei 225 Index this week

Top 3 catalysts for the Nikkei 225 Index this week

April 27, 2026
Hang Seng slips as Asian markets split; Nikkei, Kospi hit new highs

Hang Seng slips as Asian markets split; Nikkei, Kospi hit new highs

April 27, 2026
Meta, Microsoft earnings due next week: here’s what top analysts say

Meta, Microsoft earnings due next week: here’s what top analysts say

April 25, 2026

Disclaimer: ChinaSecretsRevealed.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.

No Result
View All Result
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.